Financial Perspectives’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-202
Closed -$20.5K 720
2025
Q4
$20.5K Hold
202
0.01% 431
2025
Q3
$11.1K Hold
202
﹤0.01% 511
2025
Q2
$10.7K Hold
202
﹤0.01% 503
2025
Q1
$8.74K Hold
202
﹤0.01% 517
2024
Q4
$11.3K Buy
+202
New +$12.6K ﹤0.01% 490
2021
Q4
Sell
-687
Closed -$65.6K 660
2021
Q3
$65.6K Hold
687
0.03% 211
2021
Q2
$85.4K Sell
687
-88,265
-99% -$10.5M 0.04% 203
2021
Q1
$675K Buy
88,952
+88,741
+42,057% +$12.1M 0.03% 254
2020
Q4
$28K Buy
+211
New +$25.5K 0.02% 291

Other funds holding EXAS

Financial Perspectives's EXAS Position: Q1 2026 in Review

Financial Perspectives sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 202 shares — an estimated $20.5K sold.

Financial Perspectives first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $675K in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Financial Perspectives reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Financial Perspectives sold 202 Exact Sciences shares in Q1 2026, an estimated $20.5K.
  • Financial Perspectives first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • Financial Perspectives's Exact Sciences position peaked at $675K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Financial Perspectives's 13F filing for Q1 2026, filed 11 May 2026.